Functional analysis of Zfp819 in pluripotency and embryonic development by Tan, Xiaoying
                                                                                                                                                                        
 
 
















to obtain the Ph. D. degree 
in the International Ph. D. Program for Agricultural Sciences in 
Göttingen (IPAG)  




Born in Sichuan, P.R. China 
  
Göttingen, 2012 





























Name of referee: Prof. Dr. Dr. Bertram Brenig 
Name of co-referee: Prof. Dr. med. Dr. h. c. Wolfgang Engel  
















Dedicated to my family, 



















“The significant problems we face cannot be solved by  
the same level of thinking that created them” 
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II Abstract 
Pluripotency is established and maintained by many pluripotent stem cell-specific 
transcription factors such as Oct3/4, Nanog, and Sox2 and by the function of their 
coordinated regulatory network. Several studies have explored how these pluripotency-
related factors regulate their thousands of targets by interaction with their known and 
unknown interacting partners. In the present study, we identified Zfp819 as a novel 
pluripotency-related factor and elucidated its function in pluripotent stem cells. 
In the first part of this thesis, we generated two distinct pluripotent cell type-specific 
yeast two-hybrid (Y2H) cDNA libraries which aid in identification of potential interaction 
partners and to get deeper insights into the function of a protein of interest, namely 
Zfp819. Further, ESCs cDNA library was used to screen for potential interaction partners 
of Zfp819. This screen led us to identify 17 putative interaction partners thereby to 
generate protein interactome of Zfp819. The gene ontology (GO) categorization of 
putative Zfp819 interaction proteins suggested that Zfp819 might function in regulation of 
transcription, in genome integrity maintenance, and in cell cycle/apoptosis. 
In the second part of this study, preferential expression of Zfp819 in undifferentiated 
pluripotent cell lines and epigenetic marks associated with transcriptional activation at the 
Zfp819 promoter region were identified. Additionally, we identified the region(s) 
responsible for nuclear localization of Zfp819. Further, we identified that Zfp189 functions 
in the transcriptional repression of specific endogenous retroviral elements (ERVs) in 
pluripotent cells. Through cellular and biochemical studies we show that Zfp819 interacts 
with several proteins especially Kap1 and Chd4, which are involved in genomic integrity 
maintenance. And indeed the loss of Zfp819 in ESCs results in susceptibility for DNA 
damage and impairment in DNA damage repair. Collectively, the identification of Zfp819 
interaction partners together with the molecular and functional studies revealed that 
Zfp819 functions in the regulation of genomic stability of pluripotent cells by suppressing 
a subset of ERVs. 
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Zusammenfassung 
Pluripotenz wird durch viele Stammzell-spezifische Transkriptionsfaktoren wie 
Oct3/4, Nanog und Sox2 sowie deren Funktion in ihrem regulatorischen Netzwerk 
etabliert und aufrechterhalten. Viele Studien haben gezeigt, wie diese Pluripotenz-
assoziierten Faktoren ihre Zielgene regulieren. Dies geschieht durch die Interaktion mit 
bekannten und unbekannten Interaktionspartnern. In der vorliegenden Arbeit haben wir 
Zfp819 als einen neuen Pluripotenz-assoziierten Faktor beschrieben und dessen Funktion 
in pluripotenten Stammzellen untersucht. 
Im ersten Teil der vorliegenden Arbeit haben wir zwei cDNA-Banken für Yeast two 
Hybdrid (Y2H)-Assays aus unterschiedlichen pluripotenten Stammzelltypen generiert. 
Dies hatte zum Ziel, potentielle Interaktionspartner eines Kandidatenproteins zu 
identifizieren um dadurch Eindrücke über die Funktion des Proteins zu gewinnen. Für die 
Identifizierung von potentiellen Interaktionspartnern von Zfp819 haben wir die cDNA-
Bank aus embryonalen Stammzellen benutzt. Wir konnten 17 putative Interaktionspartner 
identifizieren und daraus ein hypothetisches „Interaktom“ von Zfp819 generieren. Die 
Einordnung der putativen Interaktionspartner nach ihrer Gen-Ontologie (GO) ließ 
vermuten, dass Zfp819 eine Rolle in der Regulation der Transkription, der 
Aufrechterhaltung der genetischen Integrität und im Zellzyklus bzw. bei der Apoptose 
spielt. 
Im zweiten Teil der vorliegenden Arbeit wurde die sehr intensive Expression von 
Zfp819 in undifferenzierten pluripotenten Zelllinien gezeigt. Desweiteren konnte die 
Promotorregion von Zfp819 identifiziert werden, und es wurde gezeigt, dass diese mit 
epigenetischen Mustern ausgestattet ist. Zusätzlich konnten wir Regionen im Zfp819-Gen 
identifizieren, die für die nukleäre Lokalisation von Zfp819 verantwortlich sind. 
Desweiteren konnten wir zeigen, dass Zfp819 in der transkriptionellen Repression von 
spezifischen endogenen, retroviralen Elementen (ERVs) in pluripotenten Zellen eine Rolle 
spielt. Durch zelluläre und biochemische Studien konnten wir zeigen, dass Zfp819 mit 
vielen Proteinen interagiert (z.B. Kap1 und Chd4), welche für die Aufrechterhaltung der 
genomischen Integrität von Bedeutung sind. Tatsächlich resultierte der Verlust von 
Zfp819 in embryonalen Stammzellen in einer erhöhten Anfälligkeit für DNA-Schäden 
und in einer verminderten DNA-Reparatur. 
 
                                                                                                                Zusammenfassung                        
 4
Zusammenfassend lassen die Identifizierung der Interaktionspartner sowie die 
Ergebnisse der molekularen und der funktionellen Studien vermuten, dass Zfp819 durch 
die Unterdrückung von ausgewählten ERVs eine Rolle in der Regulation der genomischen 
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1 Introduction 
Pluripotent stem cells have the potential to differentiate into all cell types of the 
body and therefore hold a great promise for future regenerative medicine applications. 
Understanding of regulatory factors and mechanisms responsible for maintenance of 
pluripotency and differentiation potential of pluripotent cells is of prime focus. In search 
of identifying novel factors responsible for maintenance of pluripotency, we performed 
transcriptome analysis (Meyer et al., 2010) and identified Zinc finger protein 819 (Zfp819) 
as being specifically expressed in pluripotent cells but not in differentiated cells. The goal 
of the thesis was to elucidate the function of Zfp819 in pluripotent cells. 
1.1 Stem cells 
Stem cells were first discovered in early 1980’s and are known to exist in various 
organisms of a variety of species. Based on their origins, stem cells were categorized into 
embryonic stem cells (ESCs) and adult stem cells. Embryonic stem cells are generated 
from in vitro culture of inner cell mass (ICM) of blastocysts (Evans and Kaufmann, 1981; 
Martin, 1981; Thomson et al., 1998). Adult stem cells are also known as somatic stem 
cells, which are found to deposit in the niche of mature tissues throughout the body to 
maintain the tissue homeostasis (Prindull et al., 1978; Reynolds and Weiss, 1992; Shi et 
al., 2005). 
Stem cells are defined as a cell type possessing two main properties, namely the 
ability to divide unlimitedly while maintaining the undifferentiated status and the 
potential to differentiate and give rise to specialized cell types (reviewed by Sylvester and 
Longaker, 2004). According to the differentiation potential, stem cells can be divided into 
totipotent, pluripotent, multipotent and unipotent stem cells. Totipotent stem cells are 
either zygotes or the cells from early stage embryos (until ~8-16 cell stage), which have 
the capacity to form an entire organism including all three germ layers, namely endoderm, 
mesoderm, and ectoderm as well as extra-embryonic tissues (Suwinska et al., 2008). 
Unlike totipotent stem cells, pluripotent stem cells such as ESCs can also give rise to all 
three germ layers, but not to extra-embryonic tissues (Evans and Kaufmann, 1981). 
Multipotent stem cells hold the differentiation potential into several distinct cell types 
(Orkin and Zon, 2008; Blanpain and Fuchs, 2009). Unipotent stem cells, such as 
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hepatocytes, which constitute most of the liver, are more specialized and are restricted to 
produce only a single cell type (Cantz et al., 2008). 
1.2 Types of pluripotent stem cells 
Based on their origin of establishment, pluripotent stem cells are named as: 1) 
Embryonic Carcinoma Cells (ECCs), which are derived from malignant germ-cell 
teratocarcinomas (Finch and Ephrussi, 1967; Kahan and Ephrussi, 1970). 2) Embryonic 
Germ Cells (EGCs), which are derived from Primordial Germ Cells (PGCs) within 
gonadal ridges of E8.5 to E11.5 mouse embryos (Matsui et al., 1992). 3) Epiblast 
embryonic Stem Cells (EpiSC) generated from epiblast of post implantation embryos 
E5.5 to E6.5 (Brons et al., 2007; Tesar et al., 2007). 4) Multipotent Germline Stem Cells 
(mGSCs) from neonatal mouse testis (Kanatsu-Shinohara et al., 2004) and multipotent 
adult Germline Stem Cells (maGSCs) derived from adult mouse testis (Guan et al., 2006). 
In recent years, the milestone event in stem cell biology was the discovery of induced 
pluripotency from somatic cells by four transcription factors (Oct3/4, Sox2, Klf4, and c-
Myc). The factors are introduced into mouse and human somatic cells and reprogram 
them into pluripotent stem cells, widely known as induced Pluripotent Stem Cells (iPSCs) 
(Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007). The origin of 
distinct pluripotent stem cells, mentioned above, is depicted in Fig.1.1. 
Because of the wide differentiation potential of pluripotent stem cells, they offer a 
great promise for clinical treatment of individual patients suffering from cellular 
degeneration because of disease or injury (Ankrum and Karp, 2010). However, before any 
clinical attempts on human being can be tried, basic research is undoubtedly needed to 
uncover the underlying mechanisms of stem cell therapy and at the same time patients’ 
safety is also a key concern. Especially, what has to be mentioned is that the majority of 
achievements about stem cell research come from intensively investigated ESCs, “the 
gold standard of pluripotency” and mouse models. Thus, elucidation of mouse ESCs at 
basic molecular level is still of importance and prerequisite. 
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Figure 1.1 Various origins of different pluripotent stem cell types. Different types of pluripotent stem cell can be 
derived at various embryonic developmental stages. ESCs originate from ICM of E3.5 embryos; egg cylinder stage 
embryos can give rise to EpiSCs; between E8.5 and E11.5, PGCs can give rise to EGCs. Testes from both neonatal and 
adult mice can give rise to mGSC and maGSC, respectively. Moreover, germ cell tumors can give rise to ECCs. iPSCs 
can be obtained after forced expression of the four Yamanaka factors into somatic cells (Figure modified from Dejosez 
and Zwaka, 2012). 
1.3 Embryonic Stem Cells (ESCs) 
Since their first derivation in 1981, ESCs have become a widely used tool in 
biological research. ESCs proliferate rapidly, while maintaining their differentiation 
potential into all germ layers. Once exposed to extrinsic differentiation induction factors, 
they start to undergo transitions to relatively differentiated states from a self-renewing 
and pluripotent state.  
In recent years, much of the research has been engaged in fractionation of subtypes 
in ESC culture. This gave a solid evidence for ESC heterogeneity even though the global 
presence of core transcriptional factors such as Oct3/4 and Nanog. Moreover, different 
fractions of cells exhibit varying differentiation potential (Toyooka et al., 2008). Due to 
the culture condition, there is also a portion of cells which are getting relatively 
differentiated. Apparently only a subpopulation of pluripotent portion of stem cells is 
qualified to be induced for a broad range of customized specialized cell types. Therefore, 
to understand the molecular mechanisms of how pluripotency is maintained in ESCs, 
further studies are necessary for the applications of regenerative medicine. 
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1.4 Maintenance of pluripotency and differentiation potential of ESCs 
1.4.1 Transcriptional regulation of pluripotency 
Previous genome wide approaches have revealed transcriptional regulatory networks 
as primarily responsible for maintaining ESCs pluripotency (Zuo et al., 2009). However, 
only some core transcriptional factors occupy the most important positions in this 
network, such as Nanog and Oct 3/4, whose knockdown result in loss of pluripotency and 
induction of differentiation (Loh et al., 2006). Furthermore, those core factors are not 
only important for the early development of embryos and ESCs (Niwa et al., 2000; Mitsui 
et al., 2003), but also transcriptionally regulate a number of targets, including components 
of the TGF-β (e.g., TDGF1, LEFTY2/EBAF) and Wnt (e.g., DKK1, FRAT2) signaling 
pathways (Loh et al., 2006). In 2006, Sato et al. found out that Wnt signaling pathway is 
active in undifferentiated ESCs and is required for pluripotency specific gene expression 
to maintain pluripotency and self-renewal. The balance between two cytokines, leukemia 
inhibitor factor (LIF) and BMP (bone morphogenetic protein) facilitates self-renewal in 
mouse ESCs (Ying et al., 2003). However, in human ES cells, in apparent contrast, 
repression of BMP by adding inhibitor Noggin and bFGF is reported to be essential for 
maintaining the undifferentiated state (Xu et al., 2005). Question: Is there a common 
pathway for hESCs and mESCs to maintain pluripotency and how is the interaction 
relationship between different pathways? Are there other signature markers for 
pluripotency? Many questions still need to be addressed. 
mESCs provide an objective to characterize the molecular pathways that regulate the 
maintenance of the undifferentiated state as well as the events in commitment towards the 
specialized cell lineages happening in the earliest stage of embryo development. Loss of 
pluripotency results in differentiation into various cell types of the three primary germ 
layers, which is generally accompanied by downregulation of core transcription factors 
and signaling molecules that maintain the pluripotent phenotype, and upregulation of 
transcription factors involved in differentiation (Niwa et al., 2000; Velkey and O'Shea, 
2003). One of the important signaling pathways responsible for this process is the bone 
morphogenetic protein (BMP) pathway. Analysis of null mice for both BMP2 and BMP4 
gene, revealed a crucial role of BMP proteins in primordial germ cell induction (Lawson 
et al., 1999), mesoderm formation (Fujiwara et al., 2001), and extra-embryonic mesoderm 
development (Zhang and Bradley, 1996). Similarly, Serine/threonine kinase40 (Stk40), a 
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negatively controlled target of Oct3/4, can activate the Erk/MAPK pathway and induce 
endoderm differentiation (Li et al., 2010). 
Little is known about how markers of pluripotent cells are regulated during the 
differentiation of ESCs. Recent studies have shown that the Germ Cell Nuclear Factor 
(GCNF), an orphan nuclear receptor, is required for the inactivation of pluripotency 
marker genes during ESCs differentiation (Gu et al., 2005). GCNF can directly repress 
Oct3/4 and Nanog expression by binding to their promoters, when ESCs are induced to 
differentiate by retinoic acid (RA) (Gu et al., 2005). Another possible mechanism for 
GCNF mediated repression of Oct3/4 is that GCNF recruits DNA methyltransferases 
(Dnmt3a and Dnmt3b) to the Oct3/4 promoter and facilitates methylation (Sato et al., 
2006). Similarly, nucleosome remodeling and histone deacetylation (NuRD) complex is 
also known to play an important role during ESCs differentiation. ESCs lacking Mbd3 (a 
component of NuRD) display severe defects in differentiation (Kaji et al., 2007). It is 
possible that NuRD is important for silencing pluripotent marker genes, such as Nanog 
during ES cells differentiation. 
1.4.2 Epigenetic regulation of pluripotency 
Epigenetic modifications including DNA methylation and histone post-translational 
modifications (e.g. acetylation, methylation, phosphorylation, ubiquitination and ADP-
ribosylation) can regulate gene transcription and are also important in maintenance of 
ESCs pluripotency (Jenuwein and Allis, 2001). Modifications of histone proteins and 
changes in DNA methylation dictate the final outcome in transcriptional hierarchy 
mediated by transcriptional factors and are designated to alter the gene expression without 
changes of the DNA sequence. The nuclear architecture and its associated epigenetic 
modifications are depicted in Fig.1.2. 
The functional evidence for DNA methylation in early embryogenesis and 
pluripotency came from knockout mouse models. The deficiency of Dnmt1, a key DNA 
methylation maintenance enzyme, leads to a loss of 90% of DNA methylation and 
embryos die early in embryogenesis (Li et al., 1992). Dnmt3a knockout mice can develop 
to term but die several weeks after birth, while Dnmt3b deficient mice even could not 
survive until birth because of multiple developmental defects (Okano et al., 1999). 
Another DNA methylation related gene, CpG binding protein (CGBP), possesses a DNA-
binding specificity for unmethylated CpG dinucleotides and its deletion in mice gives rise 
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to reduced levels of DNA methyltransferase activity and thereby to global methylation 
(Carlone et al., 2005). The CGBP knockout ESCs exhibit increased apoptosis, and failed 
to differentiate even when exposed to differentiation conditions (Carlone et al., 2005). 
In ESCs the loss of pluripotency in response to either extrinsic cues or dedicated 
inductions results in progressive gene silencing of expression. Genes which are active in 
ESCs become gradually silenced upon differentiation induction, whereas lineage 
specification marker genes start to express with gradual loss of methylation level at their 
CpG rich regions (Deb-Rinker et al., 2005). For example, Oct3/4 and Nanog, whose CpG 
rich regions are hypomethylated in undifferentiated ESCs, become silenced with 
hypermethylation at CpG rich regions of their promoters (Lagarkova et al., 2010). 
 
Figure 1.2 Two main components of the epigenetic modifications. A. CpG methylation: methyl groups are added to 5 
position of the cytosine in context of CpG, and repress gene activity. B. Histone modifications. Various post 
translational modifications including acetylation (blue star), methylation (black circle), phosphorylation (red box), 
ubiquitination (green halfmoon) occur at the N terminus amino acid lysine (K) and serine of histones H2A, H2B, H3 
and H4. (Figure modified from http://sgugenetics.pbworks.com/w/page/47848618/Introduction%20to%20Epigentic, 
2012 and http://www.epigenetics.ch/mod.html, 2012) 
The second way of epigenetic regulation is mediated through post transcriptional 
modifications of histone N-terminal tails (Jenuwein and Allis, 2001). These histone 
modifications are known to lead to chromatin compaction and gene transcription by 
altering the interaction between histone proteins and DNA (Narlikar et al., 2002).  
Globally, the chromatin feature of undifferentiated ESCs is characterized by 
dispersed heterochromatin structure and more widely spread euchromatin, exhibiting an 
enrichment of acetylation in histone 3 (H3) and histone 4 (H4) proteins. During 
differentiation, the chromatin structure changes into more concentrated heterochromatin 
and loses the acetylation of histone proteins (Meshorer and Misteli, 2006). Expression of 
A B 
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ESCs hall mark genes (e.g. Oct3/4 and Nanog) is also related with the other activation 
histone modification marks like trimethylation at lysine 4 of H3 (3meH3K4) and 
methylation at lysine 36 of H3 (meH3K36) (Efroni et al., 2008). Interestingly, Bernstein 
et al. (2006) stated that many lineage-specific transcriptional factors such as Hox and Pax 
clusters in ESCs have bivalent modification patterns (enrichment for both activation 
histone mark (3meH3K4) and repression mark (3meH3K27)), reflecting a possible 
molecular mechanisms for regulation of ESC differentiation and maintenance of 
pluripotency.  
1.4.3 Maintenance of genome stability in ESCs 
The most important hallmark of ESCs is to give rise to all cell types of organism. 
The accumulation of mutations in the ESCs genome would be fatal to the developing 
organism and the viability of the individual. Therefore ESCs have more extensive 
mechanisms to maintain the genomic integrity and to avoid failure of organic formation 
especially for clinical application. 
Because of the nature of extraordinary length and chemical characters, DNA is prone 
to various lesions (Geacintov and Broyde, 2010). DNA damage can happen in response to 
many exogenous genotoxic stresses, including ionization such as UV, IR, and 
chemotherapeutic agents as well as endogenous DNA processing events (DNA replication) 
(Kuo et al., 1984; Torres-Ramos et al., 2002; Short et al., 2005). As shown in Fig.1.3, 
DNA damage signals immediately activate related PI3K-related kinase (PIKK) family 
proteins, Ataxia telangiectasia mutated (ATM) and Ataxia telangiectasia and Rad3 related 
protein (ATR) in mammalian cells (Abraham, 2001). ATM is mainly activated in response 
to double stranded DNA breaks resulting from ionizing radiation for example, first 
modifies early response proteins such as MDC1, which later amplify the DNA damage 
signal and transduce the signals to downstream effectors (eg, Chk2). At the end, tumor 
suppressor protein Brca1 for DNA repair can be activated (Elledge, 1996). ATM also 
phosphorylates MDM2 and p53 (Harris, 2005) and results in subsequent transcription of 
gene p21 which leads to apoptosis. ATR–ATRIP complex is recruited to the other stresses 
such as replication errors, UV exposure, it phosphorylates Chk1 which mediates the 
degradation of Cdc25A and induces S phase checkpoints. Activation of P53 by ATR is 
involved in apoptosis. 
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Figure 1.3 Distinct DNA damage response pathways activated by various stresses. DNA double strand breaks 
(DSB) resulting from ionizing radiation and DNA damage agents can be mainly recognized by ATM and ATR. In 
response to IR, ATM becomes activated and works as a DNA damage sensor, transducing the signals to down stream 
effectors (eg. Chk2). On the other hand, UV light and replication errors lead to activation of ATR and its complex. The 
down stream protein P53 can be subsequently phosphorylated in ATM/Chk2 or ATR/Chk1 dependent manner, 
respectively, in two pathways and later perform the function in cell cycle arrest and apoptosis. (Figure modified from 
Yang et al., 2003) 
In order to ensure the integrity of the genome, ESCs employ distinct mechanisms to 
guard. Once a break has occurred, cells respond by recruiting DNA repair proteins to the 
DSB sites and initiate an efficient repairing pathway to eliminate mutations (Essers et al., 
2006; Mortusewicz et al., 2008). Actually, in line with that ESCs are more stringent in 
preserving their genomic integrity than somatic cells. Spontaneous mutation frequency in 
ESCs was shown to be 100-fold lower than in somatic cells (Hong et al., 2006; 
Stambrook, 2007). By global gene expression assay, it was found that the mRNA levels 
of DNA repair related genes involved in several types of repair pathways was increased 
more significantly in ESCs than in differentiated cells (Stambrook, 2007). Alternatively, 
ESCs escape a G1 checkpoint due to moderate activation of p53 or even not activated by 
checkpoint kinase2 (Chk2), rather undergo higher incidence of apoptosis in a p53 
independent manner (Hong and Stambrook, 2004; Fluckiger et al., 2006). However, Lin 
et al. (2005) found that Nanog promoter is bound by p53 and proposed a novel function 
of p53 to promote the differentiation of mESCs by repressing Nanog, and subsequent 
apoptosis activation. 
Chromodomain helicase DNA-binding protein 4 (Chd4) was newly identified as a 
component of genome guardian machinery (Polo et al., 2010; Urquhart et al., 2011). Chd4 
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is a member of the class II family of CHD ATPases and a major subunit of Nucleosome 
Remodeling and histone Deacetylation (NuRD) complex. Knockdown of Chd4 leads to 
spontaneous DNA damage and increased irradiation (IR) sensitivity (Larsen et al., 2010). 
At the same time, Chd4 depletion disrupts DNA repair protein Brca1 assembly and 
impairs DNA damage repairing (Smeenk and Lohrum, 2010). Chd4 deficiency in bone 
marrow causes loss of lymphoid cell due to the differentiation defects in hematopoietic 
stem cell (Yoshida et al., 2008).  
Endogenous Retroviruses (ERVs), whose reactivation is often observed in cancer 
cells (Howard et al., 2008; Lamprecht et al., 2010) are involved in genome stability of 
ESCs. ERVs are variant of retroviruses, which become permanently integrated in the host 
genome and are inherited to the next generation after infection of germline cells (Urnovitz 
and Murphy, 1996; Lower, 1996). ERV sequences comprise a large proportion of the 
genome of human (10%) and mouse (8%), giving rise to extensive genomic alteration 
(International Human Genome Sequencing Consortium, 2001; International Mouse 
Genome Sequencing Consortium, 2002). Even though they are largely silenced, some 
ERVs are expressed in placenta of human and animals (Kalter et al., 1973; Levinson et al., 
1978), lymphoid cells (Medstrand et al., 1992) and mammary carcinoma cell lines 
(Patience et al., 1996). The expression of ERV was also reported in mouse germ cells and 
preimplantation embryos (Brulet et al., 1985; Poznanski and Calarco, 1991; Kigami et al., 
2003; Evsikov et al., 2004). Comparative expression patterns of ERVs in oocytes and 
preimplantation embryos revealed differential activation of several types of ERVs, due to 
their multiple stage specific promoters (Peaston et al., 2004). In this year, it was again 
emphasized that their existence is helpful for derivation of extra-embryonic tissues in 
placental mammals (Macfarlan et al., 2012). Although a large number of ERVs is 
expressed in zygotic and 2-cell stage embryos, these ERVs, especially murine endogenous 
retrovirus MuERV-L/MERVL, are highly repressed in ESCs (Maksakova et al., 2011), but 
the mechanism behind this silencing is still largely unknown.  
ERVs are able to insert into the host genome usually by copying themselves to a 
second place or migrating from the original site into a new site (known as 
retrotransposition), thereby affecting other genes and resulting in genome instability 
(Doolittle et al., 1982; Maksakova et al., 2006). As retrotransposition can be harmful for 
the genome, therefore a large number of pathways have evolved to repress the expression 
of these elements so that the harmful impact of host fitness can be minimized (Walsh and 
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Bestor, 1999; Pannell et al., 2000; Matsui et al., 2010). DNA methylation is required for 
this repression in postimplantation embryos and in several cell types derived from 
postimplantation embryos (Walsh and Bestor, 1999). However, ESCs lacking DNA 
methytransferases are normal regarding methylation level of ERV, which may reflect that 
repression of ERV occurs independent of DNA methylation and probably through histone 
modification (Leung and Lorincz, 2011). 
Kap1 (KRAB-associated protein 1), also known as TRIM28 (tripartite motif-
containing protein 28) is reported to play a very important role in embryogenesis. The 
deficient mice die before gastrulation stage at E5.5. In 2010, it was reported that Kap1 
can repress ERVs in ESCs by binding at 5’untranslated region (5’UTR) in particular IAP 
elements. Rowe et al. (2010) showed that Kap1 deletion leads to a marked upregulation of 
a range of ERVs, in particular IAP elements in ESCs as well as in early embryos. In this 
context, binding between H3K9 methyltransferase SETDB1 (ESET) and Kap1, which 
facilitates H3K9me3 of ERVs, is indispensable for the repression of ERVs (Matsui et al., 
2010). Kap1 is thought as a universal co-repressor protein which enables the repressing 
target genes of Zinc finger proteins, especially KRAB (Krüppel Related Associated Box)-
zinc finger proteins (Friedman et al., 1996; Ryan et al., 1999; Sripathy et al., 2006). 
1.5 Zinc finger proteins and their roles in ESCs 
Zinc finger proteins are believed to belong to the most abundant of eukaryotic 
proteins, 2-3% of human proteins are zinc finger proteins (Lander et al., 2001). Many of 
them harbor a KRAB domain, which is responsible for either gene activation or repression 
and protein-protein interactions (Margolin et al., 1994). In addition, they bear several 
classic Cys2His2 zinc finger motifs which enable the recognition of a specific DNA 
sequence, thus functioning in transcriptional regulation of target genes (Klug, 1999; 
Wolfe et al., 2000).  
A growing body of literature suggests that zinc finger proteins play an important role 
in maintenance of ESCs pluripotency, differentiation potential, proliferation, and cell 
cycle control. Zinc finger protein 206 (Zfp206) is known to regulate ESCs gene 
expression and differentiation and its expression is also considered as a hallmark of 
pluripotent cells (Zhang et al., 2006b; Wang et al., 2007). Likewise, expressed Zfp42, also 
known as Rex1, is restricted to undifferentiated stem cells and is known to maintain the 
undifferentiation state, as the depletion of Rex1 was found to promote the expression of 
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three germ layer markers (Scotland et al., 2009). Recently, CtBP-interacting BTB Zinc 
Finger Protein (CIBZ) was shown to be a key transcriptional regulator of ESCs 
proliferation and played a role in G1/S transition partly depending on Nanog protein 
expression (Nishii et al., 2012). 
About one third of zinc finger proteins bear a KRAB domain with a total number of 
about 200 genes in human and in mouse (Lander et al., 2001; Waterston et al., 2002). 
They have transcriptional repression function facilitated by the co-repressor Kap1. Kap1 
recruits the heterochromatin proteins (HP1), histone deacetylases (HDACS), and SETDB1 
and form into a protein complex, which promotes the heterochromatin formation and 
leads to target genes silencing (Urrutia, 2003). KRAB zinc finger proteins and Kap1 
mediated gene repressions are connected to a variety of processes, including stem cell 
self-renewal and pluripotency, early embryogenesis (development and differentiation), 
DNA damage, and genomic imprinting (Cammas et al., 2002; Cammas et al., 2004; Li et 
al., 2008; Hu et al., 2009; Tian et al., 2009). Interestingly, the KRAB and Kap1 mediated 
transcriptional regulation even facilitates repressing of promoters located several tens of 
kilobases away from the primary repressor site (Groner et al., 2010). Zfp568 is 
indispensible to control morphogenesis of embryonic and extra-embryonic tissues 
(Shibata and Garcia-Garcia, 2011), but Kap1 is differentially required for this function in 
a tissue specific manner (Shibata et al., 2011). Moreover, Zfp57 maintains the genomic 
imprints in ESCs in a Kap1 dependent manner, its loss leads to depletion of methylation 
at several imprinted regions (Zuo et al., 2011). In ESCs, KRAB zinc finger protein 
Zfp809 was found as a retrovirus restriction factor, by recruiting Kap1 to regulate the 
silencing of ERVs (Wolf and Goff, 2009). Even though numerous investigations were 
documented about functional analysis of KRAB zinc finger proteins, the function of a 
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1.6 Aims 
This study was aimed to elucidate the function of Zfp819, a novel putative mouse 
ESC specific marker, which we have identified as being highly expressed in mESCs but 
not in their differentiated counterparts. Towards this end, the present study was divided 
into four aspects as listed below: 
1. Spatial and temporal expression analysis of Zfp819. 
2. Functional analysis of Zfp819 in pluripotent stem cells, especially in ESCs. 
3. Identification and characterization of Zfp819 interaction proteins. 
4. Generation of loss-of-function and gain-of-function mouse models to decipher the 
function of Zfp819 during early embryogenesis. 
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2 Materials and methods 
2.1 Materials 
2.1.1 Animals 
The used mouse strains C57BL/6J, 129/Sv, CD-1 were initially purchased from 
Charles River Laboratories, Wilmington, USA, and maintained as colonies at the Animal 
Facility of the Institute of Human Genetics, Goettingen. ROSA26CreERT (Vooijs et al., 
2001) and EIIaCre (Lakso et al., 1996) mice were kindly provided by Prof. Hahn, 
Institute of Human Genetics, Goettingen. All experiments involving mice were 
performed according to protocols authorized by the Institutional Animal Care and Use 
Committee of the University of Goettingen. 
2.1.2 Equipment 
The equipment used in this study is listed in Table 2.1. 
Table 2.1 Equipment used in present study 
Equipment Company Location of Company 
7900HT Real Time PCR System Applied Biosystems USA 
Autoclave  Webeco Germany 
Bioruptor Sonicator Diagenode Belgium 
Bisulfite Pyrosequencing System Biotage Sweden 
CO2 Incubator (MCO-20AIC) SANYO Japan 
Eppendorf Centrifuge (5415D) Eppendorf Germany 
GS Junior Sequencing System Roche USA 
Heidolph Reax Vortex Heidolph Germany 
Heraeus Megafuge 16R Thermo Scientific Germany 
Heraeus Multifuge X3R Thermo Scientific Germany 
Invert Microscope (Primo Vert) Carl Zeiss Germany 
Laminar Airflow Thermo Scientific Germany 
Microcentrifuge (Heraeus Fresco 21) Thermo Scientific Germany 
Microscope (BX60) Olympus Germany 
NanoDrop Spectrophotometer (ND-1000) Thermo Scientific Germany 
PCR Machine PeQlab Germany 
Pipettes Gilson France 
Refrigerator (+4°C)  Privileg Germany 
Refrigerator (-152°C) SANYO Japan 
 
                                                                                                         Materials and methods                         
 23
Table 2.1 Continued   
Equipment Company Location of Company 
Refrigerator (-20°C)  LIEBHERR Germany 
Refrigerator (-80°C)  SANYO Japan 
Semi-Dry-Blot  Biometra Germany 
Sonicator (Branson sonifier 250) Branson  USA 
Thermomixer 5436 Eppendorf Germany 
Water Bath Labortechnik Germany 
X-Ray Automatic Processor (Curix 60) Agfa Germany 
2.1.3 Chemicals and kits 
The chemicals and kits used for this thesis are included in Table 2.2. 
Table 2.2 Chemicals and kits used in present study 
Chemicals and kits Company Location of Company 
2-Mercaptoethanol Gibco/ BRL Eggenstein, Germany 
1-bromo-3-chloropropane (BCIP) Boehringer Mannheim, Germany 
4′,6-Diamidino-2-Phenylindole 
Dihydrochloride (DAPI) 
Vector Labs  Burlingame, Germany 
Anti-Actin antibody Sigma-Aldrich Deisenhofen,Germany 
Anti-Chd4 antibody  Abcam Cambridge, UK 
Anti-E2-tag antibody (Mouse monoclonal) Abcam Cambridge, UK 
Anti-E2-tag antibody (Rabbit polyclonal)  Lifespan  Eching, Germany 
Anti-H3f3b antibody Abcam Cambridge, UK 
Anti-H3K27me3 antibody Millipore Darmstadt, Germany 
Anti-H3K4me3 antibody Active Motif La Hulpe, Belgium 
Anti-H3K9ac antibody Abcam Cambridge, UK 
Anti-H3K9me3 antibody Millipore Darmstadt, Germany 
Anti-Kap1 antibody Cell Signaling Frankfurt, Germany 
Anti-Myc-tag antibody Millipore Darmstadt, Germany 
Anti-Nanog antibody Abcam Cambridge, UK 
Anti-Oct4 antibody Abcam Cambridge, UK 
Anti-p-H2A.X (Ser139) antibody Cell Signaling Frankfurt, Germany 
Anti-p-p53 (Ser15) antibody Cell Signaling Frankfurt, Germany 
Anti-Sox2 antibody Abcam Cambridge, UK 
Anti-α-tubulin (Mouse monoclonal) antibody Sigma-Aldrich Deisenhofen,Germany 
Anti-α-tubulin (Rabbit polyclonal) antibody  Sigma-Aldrich Deisenhofen,Germany 
Bacto-Tryptone Difco Detroit, USA 
Bacto-Yeast-Extract Difco Detroit, USA 
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Table 2.2 Continued   
Chemicals and kits Company Location of Company 
Bisulfite Pyrosequencing Kit Biotage Uppsala, Sweden 
BL21 (DE3) Competent Cells Novagen Darmstadt, Germany 
Chemiluminescent Substrate Pierce Rockford, USA 
Chloroform Baker Deventer, Netherlands 
Collagenase  Sigma-Aldrich Deisenhofen,Germany 
Coomassie Blue G-250 Sigma-Aldrich Deisenhofen, Germany 
DH5α-Bacteial-Competent Cells Invitrogen  Karlsruhe, Germany 
Diethylpyrocarbonate (DEPC) Sigma-Aldrich Deisenhofen, Germany 
Dropout (DO) Supplement Clontech  Heidelberg, Germany 
Dulbecco’s-Modified-Eagles-Medium (DMEM)  PAN Aidenbach, Germany 
Endo Free Plasmid Maxi Kit Qiagen Hilden, Germany 
Fetal Bovine Serum (FBS) PAN Aidenbach, Germany 
Gelatin Sigma-Aldrich Deisenhofen, Germany 
Goat anti-mouse IgG-alkaline phosphatase conjugate Sigma-Aldrich Deisenhofen,Germany 
Goat anti-mouse IgG-Cy3 conjugate Sigma-Aldrich Deisenhofen, Germany 
Goat anti-mouse IgG-FITC conjugate Sigma-Aldrich Deisenhofen, Germany 
Goat anti-rabbit IgG-alkaline phosphatase conjugate Sigma-Aldrich Deisenhofen,Germany 
Goat anti-rabbit IgG-Cy3 conjugate Sigma-Aldrich Deisenhofen, Germany 
Goat anti-rabbit IgG-FITC conjugate Sigma-Aldrich Deisenhofen, Germany 
GST•BindTM Kits Novagen Darmstadt, germany 
Hybridisation Solution Amersham Freiburg, Germany 
Hydrochloric Acid (HCl) Merk Darmstadt,Germany 
Immunoprecipitation Kit (Protein A) Roche Penzberg, Germany 
Leukemia Inhibitory Factor (LIF) Chemicon Temecula, USA 
L-Gultamine PAN Aidenbach, Germany 
Lipofectamine 2000 Invitrogen Karlsruhe, Germany 
Maxi Plasmid Kit  Qiagen Hilden, Germany 
Mega Plasmid Kit Qiagen Hilden, Germany 
Midi Plasmid Kit  Invitrogen Karlsruhe, Germany 
Mitomycin C Sigma-Aldrich Deisenhofen, Germany 
Nitro-blue Tetrazolium (NBT) Roche Penzberg, Germany 
Nitrocellulose Membrane Amersham Freiburg, Germany 
Non Essential Amino Acids (NEAA)  Invitrogen Karlsruhe, Germany 
NuPAGE MOPS SDS Running Buffer Invitrogen  Karlsruhe, Germany 
NuPAGE Novex Bis-Tris 4-12% Gels Invitrogen  Karlsruhe, Germany 
Nylon Membrane Amersham Freiburg, Germany 
OneDay ChIP Kit Diagendode Liège, Belgium 
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Table 2.2 Continued   
Chemicals and kits Company Location of Company 
OptiMEM I Invitrogen Karlsruhe, Germany 
Paraformaldehyde (PFA) Merck,  Darmstadt,Germany 
Penicillin/Streptomycin PAN Aidenbach, Germany 
Peptone Carl Roth Karlsruhe, Germany 
pGEM-T Vector System Promega Mannheim, Germany 
Phosphate Buffered Saline (PBS) PAN Aidenbach, Germany 
Platinum Taq DNA Polymerase Invitrogen Karlsruhe, Germany 
Protein A/G PLUS Agarose SantaCruz  Heidelberg, Germany 
Proteinase K Roche Penzberg, Germany 
Proximity Ligation Assay (PLA) kit Bethyl Hamburg, Germany 
QIAprep Spin Miniprep Kit. Qiagen Hilden, Germany 
QIAquick PCR Purification Kit Qiagen Hilden, Germany 
Rapid Immunoprecipitation (RIPA) Buffer Millipore Darmstadt, Germany 
Restriction Enzymes Invitrogen Karlsruhe, Germany 
RNase A Qiagen Hilden, Germany 
SeeBlue Plus2 Pre-Stained Standard Invitrogen  Karlsruhe, Germany 
Shearing ChIP kit - 100 Diagendode Liège, Belgium 
Sodium Chloride (NaCl) Merck Darmstadt,Germany 
Sodium Pyruvate Gibco/ BRL  Eggenstein, Germany 
SuperScript II Reverse Transcriptase Invitrogen Karlsruhe, Germany 
SYBR Green Master Mix Qiagen Hilden, Germany 
T4 DNA Ligase Promega Mannheim, Germany 
Triton X-100 Serva Heidelberg, Germany 
Trizol Reagent  Invitrogen Karlsruhe, Germany 
Trypsin PAN Aidenbach, Germany 
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2.1.4 Primers 
The primers used in this study are listed in Table 2.3. 
Table 2.3 Primers used for ChIP PCR, cloning, and genotyping 
Name Primer sequence (5′-3′) Application
Actin chip F CCCCAACACACCTAGCAAAT ChIP-PCR
Actin chip R ACTGCCCCATTCAATGTCTC ChIP-PCR
Chd4 F GAATTCCAGTGGAAAAGGCAGAGGTGA Cloning 













GL3_IAP U3_F GGTACCTTCAGTGTCCTAGTTCCCTTCC Cloning 
GL3_IAP U3_R GCTAGCGCCTGGCTTACAGGTTCAGA Cloning 
H3f3b F GAATTCAAATGGCCCGAACCAAGCAGA Cloning 
H3f3b R GCGGCCGCTTAAGCTCTCTCCCCCCGTA Cloning 
Hnf4 qRT _F CCACATGTACTCCTGCAGGTTTAG qPCR 
Hnf4 qRT _R CGCTCATTTTGGACAGCTTC qPCR 
Hoxa11 chip F AGAAGTGCCTCTGGCTCTGA ChIP-PCR
Hoxa11 chip R GATTTGCACGGTGACTTGATT ChIP-PCR
Hprt F AGCCCCAAAATGGTTAAGGTTGC qPCR 
Hprt R TTGCAGATTCAACTTGCGCTCAT qPCR 
IAP qRT _F AGCAGGTGAAGCCACTG qPCR 
IAP qRT _R CTTGCCACACTTAGAGC qPCR 
IAP_5′UTR F CGGGTCGCGGTAATAAAGGT ChIP-PCR
IAP_5′UTR R ACTCTCGTTCCCCAGCTGAA ChIP-PCR
IAP_gag F TTTCTTAAAATGCCCAGGCTTT ChIP-PCR
IAP_gag R CTTGCCCTTAAAGGTCTAAAAGCA ChIP-PCR
IAP_Poly F CTTGCCCTTAAAGGTCTAAAAGCA ChIP-PCR
IAP_Poly R GCGGTATAAGGTACAATTAAAAGATATGG ChIP-PCR
IAP_U3 F CGAGGGTGGTTCTCTACTCCA ChIP-PCR
IAP_U3 R GACGTGTCACTCCCTGATTGG ChIP-PCR
KAP1_RBCC_F GAATTCCTTCTGGAGCACTGCGGCGTGTGT Cloning 
KAP1_RBCC_R CCCGGGCTAATCCACAATCATTTTGAGGGC Cloning 
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Table 2.3 Continued   
Name Primer sequence (5′-3′) Application
Klf4 qRT _F TCAGGTACCCCTCTCTCTTCTTC qPCR 
Klf4 qRT _R CGCTTCATGTGAGAGAGTTCCT qPCR 
Line1 qRT _F TTTGGGACACAATGAAAGCA qPCR 
Line1 qRT _R CTGCCGTCTACTCCTCTTGG qPCR 
Mest F CAGCAGCTTCTGGCATGTGG ChIP-PCR
Mest R AACCCCAGATTCTAGTGAAG ChIP-PCR
Nanog qRT _F TTACAAGGGTCTGCTACTGAGTG qPCR 
Nanog qRT _R CAGGACTTGAGAGCTTTTGTTTG qPCR 
Nestin qRT _F AGCAGGAGAAGCAGGGTCTAC qPCR 
Nestin qRT _R GCTGTCACAGGAGTCTCAAGG qPCR 
Oct4 chip F TGGGCTGAAATACTGGGTTC ChIP-PCR
Oct4 chip R TTGAATGTTCGTGTGCCAAT ChIP-PCR
Oct4 qRT _F CGGAAGAGAAAGCGAACTAGC qPCR 
Oct4 qRT _R GCCTCATACTCTTCTCGTTGG qPCR 
Overexpression E2 F GTCGACGATGGCTGCTGACATGAATTTCTG Cloning 
Overexpression E2 R GCGGCCGCTTAGCGATCTCTAAAATCAGAAGAA 
GTACTTGAACCACCAGGGTTCTCACCAGTGTGAG 
Cloning 
Zfp819_GST_N_F CCATGGAGATGGCTGCTGACATGAATTTC Cloning 
Zfp819_GST_N_R GCGGCCGCCAGGCTGGATGTACTGGGAAG Cloning 
Zfp819_GST_FL_F CATGGAGATGGCTGCTGACATGAATTTC Cloning 
Zfp819_GST_FL_R GCGGCCGCAGGGTTCTCACCAGTGTGAG Cloning 
Sine B1 qRT _F GTGGCGCACGCCTTTAATC qPCR 
Sine B1 qRT _R GACAGGGTTTCTCTGTGTAG qPCR 
Vimentin qRT _F TGCAGTCATTCAGACAGGATGT qPCR 
Vimentin qRT _R ATCTCTTCATCGTGCAGTTTCTTC qPCR 
Zfp206 qRT _F GAGAGGAGGTGGTACAGCTATTG qPCR 
Zfp206 qRT _R AGGTGGAGGTAACTCATTCAGTG qPCR 
Zfp819 qPCR F GTATTCCAGGCCAGAGGTCA qPCR 
Zfp819 qPCR R CAGCCTTCACACACATTTGG qPCR 
Zfp819_3MA_F AAGCTTACTGTGGGGTGACTGAGGAG Cloning 
Zfp819_3MA_R GGATCCGGCTGAAGAAAGCACCAGAA Cloning 
Zfp819_3ProbeF CCCTCAGCAACCATTTATGC Cloning 
Zfp819_3ProbeR GACAAACAATTTCCCGCAGT Cloning 
Zfp819_5MA_F GCGGCCGCGCATGCACAAAATAGGCAGA Cloning 
Zfp819_5MA_R AAGCTTGGGGTAGGGGGATAGCATTA Cloning 
Zfp819_5ProbeF TCGGGAAAGAGGATGATGTC Cloning 
Zfp819_5ProbeR CCTGAGCTACGGAACTGGAG Cloning 
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Table 2.3 Continued   




















Zfp819_GST_F CCATGGAGATGGCTGCTGACATGAATTTC Cloning 
Zfp819_GST_R GCGGCCGCCAGGCTGGATGTACTGGGAAG Cloning 
Zfp819_KRAB_F GAATTCAGATTGGTGTCCTTTGAGGATG Cloning 
Zfp819_KRAB_R CCCGGGCTAACACCTCTGATGTGGGAAATC Cloning 
Zfp819_NCL_NF GTCGACCATGGCTGCTGACATGAATTTC Cloning 
Zfp819_NCL_NR GCGGCCGCTTACAGGCTGGATGTACTGGGAAG Cloning 
Zfp819_NCL_CF GTCGACCCCTCAGCAACCATTTATGC Cloning 
Zfp819_NCL_ CR GCGGCCGCCTAAGGGTTCTCACCAGTGTG Cloning 
Zfp819_YH_ CF CCATGGACCCTCAGCAACCATTTATGC Cloning 
Zfp819_YH_CR CCCGGGCTAAGGGTTCTCACCAGTGTG Cloning 
Zfp819_YH_NF CCATGGCAATGGCTGCTGACATGAATTTC Cloning 
Zfp819_YH_NR CCCGGGTTACAGGCTGGATGTACTGGGAAG Cloning 
Zfp819NCL_C328F AAGCTTCGCATGGATGTCCTGGCTGTCGG Cloning 
Zfp819NCL_C394R GGATCCGCTAAAGGCCTTCCCACAGTC Cloning 
Zfp819NCL_C469F AAGCTTCGAGATGCTGCGACTGTGGGAAG Cloning 
Zfp819NCL_C534R GGATCCAGACATGGCCTTCCCACAGTC Cloning 
Zfp819TS3U0102F TGTGTGCAGTTGTTTGCTCA RT-PCR 
Zfp819TS3U0102R AAAGCCTTTCACAGGTCCAA RT-PCR 
Zfp819TS3U01R CAAATTCTTTATTCTTTTCCT CAG GT RT-PCR 
Zfp819TS5U0103F CCAAGACATTCATGCTGCTG RT-PCR 
Zfp819TS5U02F GGATTCTGAACACTGGGGAAT RT-PCR 
Zfp819TS5U03F GATGACTGAGGCAGCTGTAGG RT-PCR 
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Table 2.3 Continued   
Name Primer sequence (5′-3′) Application
Zfp819TS5UR CACTCCTCCTGGCTGAAGTT RT-PCR 
Znf175qRT _F GAGTGGAGATGCCTGCTGAT qPCR 
Znf175qRT_R CACTCCTCCCTGCTGAAGTC qPCR 
2.1.5 Solutions, buffers, and culture media 
Solution, buffers, and culture media are prepared as shown in Table 2.4. 
Table 2.4 Solution, buffers, and culture media used in this study 
Name Compositions 
Alkaline Phosphatase (AP)-Buffer 100 mM NaCl 
50 mM MgCl2 
100 mM Tris/HCl (pH 9.5) 
Blocking Buffer for Immunocytochemistry 0.2%Triton in PBS 
Blocking Buffer for Western Blot 10 mM Tris-HCl (pH 7.3) 
137 mM NaCl 
0.1 % Tween 20 
Denaturation Solution 1.5 M NaCl 
0.5 M NaOH 
Depurination Solution  250 mM HCl 
DNA Extraction Buffer 100 mM Tris-HCl (pH8.0) 
5 mM EDTA 
0.2% SDS 
200 mM NaCl 
100 μg/ml Proteinase K 
Embryonic Stem (ES) Cell Culture Medium DMEM  
20% FBS 
1 mM NEAA 
1 mM Sodium pyruvate 
10 μM 2-Mercaptoethanol 
2 mM L-Glutamine 
1000 U/ml LIF 
1 mM Penicillin/streptomycin 





65% Culture medium 
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Table 2.4 Continued  
Name Compositions 
Luria Bertani (LB) Medium for Bacteria 1 % (w/v) Tryptone 
0,5 % (w/v) Yeast Extract 
1 % (w/v) NaCl 
Mouse Embryonic Fibroblasts (MEFs) Culture Medium DMEM 
2 mM L-Glutamine 
10% FBS 
1% Penicillin/streptomycin 
Neutralisation Solution 1.5 M NaCl 
1 M Tris/HCl (pH 7.0) 
Protein Extraction Buffer 10 mM Tris–HCl (pH 8.0) 
1 mM EDTA 
2.5% SDS 
1 Protease inhibitor cocktail 
tablet/10 ml buffer 
100 mM PMSF 
Protein Transfer Buffer (10x) 25 mM Tris-HCl (pH 8.3) 
150 mM Glycine 
20% Methanol 
Saline Sodium Citrate (SSC) (20x) Solution 3 M NaCl 
0.3 M sodium citrate (pH 7.0) 
Tris/Borate/EDTA (TBE) Buffer (5x) 
 
 
Tris/EDTA (TE) Buffer 
450 mM Tris base 
450 mM Boric acid 
20 mM EDTA (pH 8.0) 
10 mM Tris/HCl (pH 8.0) 
1 mM EDTA 
 
Yeast Peptone Dextrose Adenine 
(YPDA) Medium for Yeast 
20 g/L Difco peptone  
10 g/L Yeast extract  
20 g/L Agar (for plates only) 
935 ml H2O  
50 ml 40% glucose (to be added freshly)  
15 ml 0.2% Adenine sulfate (to be added freshly) 
Yeast Standard (SD) Medium  1.7 g Yeast nitrogen base without amino acids 
5 g Ammonium sulfate 
600 mg DO Supplement 
20 g Agar (for plates only)  
950 ml H2O (pH 5.8)                                            
50 ml 40% Glucose (to be added freshly) 
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2.2 Methods 
2.2.1 Cell culture 
The mouse ESC line (ES R1) with 129/Sv genetic background was maintained as 
described previously (Zechner et al., 2009). Briefly, the undifferentiated ESCs were 
cultured on gelatin-coated flask, plated with Mitomycin C-inactivated MEFs as feeder 
layer using ESC culture medium (see section 2.1.5). MEFs were cultured in MEFs culture 
medium (see section 2.1.5) until cells became confluent, then treated with 10 g/ml 
Mitomycin C in MEFs culture medium. After 2-3 h of incubation, cells were washed 
twice with PBS and collected by trypsinization and centrifugation. Next, they were 
resuspended in MEFs culture medium and plated onto culture flasks, which were 
pretreated with 0.1% gelatin for 30 min. The feeder cells were left to attach by incubation 
overnight (O/N) at 37°C, 5% CO2. Before plating ESCs on feeder layer, the medium was 
changed to ESC culture medium. NIH-3T3 cells obtained from Dr. S. A. Aaronson 
(Bethesda, U.S.A.), were cultured using MEFs culture medium. 
2.2.2 Genomic DNA extraction, genotyping, and promoter methylation analysis 
Mouse tail tips or cell pellets were incubated in 700 μl of DNA extraction buffer at 
55°C O/N in thermomixer. The resulting lysates were centrifuged at 13,000 xg for 10 min 
and genomic DNA (gDNA) was purified from the supernatant by phenol chloroform 
extraction, followed by precipitation with isopropanol and washing the pellet with 70% 
ethanol. The gDNA pellet was then dissolved in 50 μl of dH2O and used for either 
genotyping or promoter methylation analysis. For the latter experiment, EpiTect Bisulfite 
Kit was used for bisulfite treatment of gDNA, and then the methylation status of the 
promoter region of the gene of interest was analyzed by bisulfite pyrosequencing using 
PSQTM 96MA Pyrosequencing System with the PyroGold SQA reagent kit. Pyro Q-CpG 
software was applied for pyrosequencing result analysis (Zechner et al., 2009). 
2.2.3 Total RNA isolation, cDNA synthesis, RT-PCR, and quantitative real time 
PCR 
Total RNA was extracted from cells or tissues using Trizol Reagent following the 
manufacturer’s protocol. In order to avoid any RNase activity, special RNase-free 
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Eppendorf cups and DEPC-treated dH2O were used during the procedure. About 100 mg 
of tissue or ~106-107 cells were homogenized in 1 ml of Trizol Reagent using a glass-
teflon homogenizer. The homogenate was vortexed and incubated on ice for 5 min to 
permit the complete dissociation of nucleoprotein complexes. Then 0.2 ml of cold 
chloroform was added, mixed vigorously, kept on ice for 10 min. After centrifugation at 
13,000 xg for 15 min at 4°C, the upper aqueous phase was transferred into a new 
Eppendorf cup. By adding 0.5 ml isopropanol, RNA was precipitated and subsequently 
washed with 75% ethanol. Finally, the RNA pellet was dissolved in ~50 μl of DEPC-
dH2O and stored at -80°C. 
For cDNA synthesis, 5 μg of total RNA was digested with DNaseI to avoid any 
gDNA contamination and used in SuperScriptII Reverse Transcriptase system. 0.3 μl of 
cDNA was used for checking the cDNA synthesis quality by RT-PCR with housekeeping 
gene HPRT. For quantitative Real Time PCR (qPCR) analysis, the reaction composed of 
1 μl diluted cDNA (1/20), 5 μl 2x SYBR Green Master Mix, 1 μl forward primer, 1 μl 
reverse primer, 2 μl dH2O was run in ABI7900 Real-Time PCR System. Primers used in 
RT-PCR and qPCR are listed in section 2.1.4 Primers. The qPCR data were analyzed by 
the delta-delta-Ct method. 
2.2.4 Protein extraction and Western blotting  
For protein extraction, ~100 mg of mouse tissues or 1 x 107 cells were homogenized 
in 300-500 μl of protein extraction buffer, incubated on ice for 40 min and sonicated and 
followed by centrifugation at 13,000 xg for 20 min at 4°C. The protein extracts (40 μg) 
were resolved on 4-12% SDS-PAGE and transferred onto nitrocellulose membrane using 
semi dry blotting method at 150 mA for 15 min and 300 mA for 45 min. Next, the 
nitrocellulose membrane was blocked in 5% blocking buffer at room temperature (RT) 
for 1 h and then incubated with primary antibody for O/N at 4°C. For primary antibody, 
mouse monoclonal anti-myc tag (1:1500), mouse or rabbit monoclonal anti-E2-tag 
(1:1000), rabbit monoclonal anti-Kap1 (1:1000), mouse monoclonal anti-Chd4 (1:1000), 
and mouse monoclonal anti-α-tublin (1:10000) diluted in 2 % non-fat milk in blocking 
buffer were used. Next day, the membrane was washed three times for 10 min with 2 % 
non-fat milk in blocking buffer at RT and incubated for 1-2 h at RT with either alkaline 
phosphatase- or horseradish peroxidase-conjugated anti mouse/rabbit IgG secondary 
antibody (1:5000). Then, the membrane was washed three times for 10 min with 2 % 
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non-fat milk in blocking buffer at RT and one time for 5 min in PBS at RT. Finally, 
signals were visualized using either BCIP-NBT system or Chemiluminescence detection 
method. 
2.2.5 Plasmid DNA transfection and immunocytochemistry 
For transfection, approximately 0.5 × 105 NIH-3T3 cells were plated one day before 
transfection on cover slips in 24-well plates. For transfection into ESCs, 0.5 × 105 ESCs 
were plated 5 h before transfection. 1 μg of plasmid DNA and 2.5 μl of Lipofectamine 
2000 reagent were diluted in 50 μl of OptiMEM, separately, and incubated at RT for 5 
min. Subsequently, the diluted Lipofectamine and DNA were mixed together and 
incubated for additional 20 min at RT for allowing complex formation. Meanwhile, cells 
were washed twice with PBS and 400 μl of DMEM medium was applied in each well. 
After completion of the incubation, the DNA-Lipofectamine complex was added drop by 
drop to the cells and incubated for 3 h at 37°C .Then medium was changed back to 
normal MEF culture medium or ESC culture medium and the cells were further incubated 
for 24-48 h at 37°C and 5% CO2.  
For immunostaining, the cells were fixed with 4% PFA for 30 min at RT and then 
incubated with 50 mM NH4Cl for 10 min. Later the cells were permeabilized by three 
times incubation with 0.2 % Triton in PBS for 4 min each at RT. 1:100 diluted primary 
antibodies were added followed by incubation for 1 h at RT. After washing, the 
secondary antibody conjugated with either FITC or Cy3 in PBS containing 0.2% Triton 
was added and incubated for additional 1 h. After incubation, cells were washed three 
times with 0.2 % Triton in PBS and were mounted with DAPI and proceeded to 
fluorescence microscopic analysis. Cells expressing EGFP fluorescence proteins were 
directly mounted with DAPI after fixation with 4% PFA. 
For transfection in 6-well plate, 2 × 105 cells were used and transfected with 2 μg of 
plasmid DNA and 5 μl of Lipofectamine complex prepared in a total of 200 μl OptiMEM, 
after 24-48 h of transfection, cells were subjected to protein extraction and used either 
directly for Western blot analysis or for co-immunoprecipitation experiments. 
2.2.6 Co-immunoprecipitation and Proximity Ligation Assay 
For immunoprecipitation experiments, ESCs were transiently transfected with an 
appropriate construct using Lipofectamine 2000. After 48 h, proteins were isolated by 
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using RIPA buffer, followed by centrifugation at 13,000 xg, 4°C, 20min. Co-
immunoprecipitation was done using the Immunoprecipitation Kit (Protein A) in 
accordance with the manufacturer’s protocol. Briefly, to reduce the background caused 
by non-specific adsorption of irrelevant cellular proteins to protein A/G-agarose, a pre-
clearing step was done by incubating 300 µg -500 µg of protein extract with 50 µl protein 
A/G-agarose suspension for 3 h. Then, the samples were centrifuged at 5,000 × g for 30 
sec and the resulting supernatants were transferred into fresh tubes in which 6µg of 
appropriate antibody was added. Protein-antibody mixtures were incubated at 4°C for 2-3 
h. After that, mixtures were incubated O/N at 4°C with 50 µl freshly prepared protein 
A/G-agarose beads. The next day, samples were centrifuged at 5,000 × g for 30 sec, and 
the beads were washed with washing buffer I, buffer II and buffer III for 20 min 
respectively. Finally, the beads were resuspended in 50 µl SDS-PAGE-loading buffer, 
and then eluted proteins were denatured and loaded onto 4-12% SDS-PAGE. Western 
blot analysis was performed with indicated antibodies. 
In Proximity Ligation Assay (PLA), NIH-3T3 cells which were plated on cover slip 
in a 4-well plate were transiently transfected with indicated constructs. After 24 h of 
transfection, the cells were processed using the protocol provided with the PLA kit. 
Briefly, one drop of blocking solution was added onto the cover slip and the plate was 
incubated in a pre-heated humidity chamber for 30 min at 37°C. After that, the 1:100 
diluted indicated primary antibodies in antibody diluent were added onto each well after 
tapping off the blocking solution and incubated at RT. After 1 h of incubation, cover slips 
were washed two times for 5 min each with wash buffer A, then the 1:5 diluted PLA 
probes PLUS and MINUS in antibody diluent were added into each well and incubated in 
a pre-heated humidity chamber for additional 1 h at 37°C. Next, the probe solution was 
removed followed by two times washing with wash buffer A for 5 min each. 
Subsequently, 40 µl Ligation-Ligase solution diluted in pure water was added onto cover 
slips and incubated in humidity chamber for 30 min at 37°C. After washing two times for 
2 min each with wash buffer A, cover slips were exposed to 40 µl Amplification-
Polymerase solution diluted in pure water and left in a pre-heated humidity chamber for 
100 min at 37°C. Finally, the cover slips were washed two times for 10 min each with 
wash buffer B followed by an additional washing with 0.01 x wash buffer B. The 
coverslips were mounted by DAPI and analyzed by fluorescence microscope. 
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2.2.7 Chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) assay was done according to the protocol 
provided with the Shearing Kit and OneDay ChIP Kit. Briefly, the wild type ESCs or 
ESCs transfected with hEF1α-Zfp819-E2 construct were trypsinized to get the cell pellet. 
For each preparation, 3 × 106 cells were used for shearing and subsequent chromatin 
preparation. After washing with PBS, cells were resuspended with 600 µl ESCs medium 
supplemented with 45 µl buffer A and 20 µl formaldehyde, incubated at RT for fixation 
and cross-linking. After 10 min, cross-linking was immediately quenched with the 
addition of 66 µl of 1.25 M glycine. Cells were lysed by 10 min incubation in lysis buffer 
B and C on ice, followed by centrifugation at 1,600 xg for 5 min at 4°C. Afterwards, the 
cell pellets were resuspended in buffer D containing protease inhibitors and sonicated (30 
seconds “ON” / 30 seconds “OFF” and 30 cycles) using Bioruptor to obtain an average 
DNA fragment chromatin length of ~200-500 bp.  
For immunoprecipitation, soluble chromatin was pre-cleaned by incubation with 
protein A/G sepharose beads for 3 h at 4°C. At the same time, freshly washed protein 
A/G sepharose beads were incubated with 5 µg antibody against E2, Oct4, Sox2, and 
Nanog, separately, for 1 h at 4°C to form the beads-antibody complex. As a negative 
control either rabbit or mouse IgG was used. After pre-cleaning, the samples were added 
into washed bead-antibody complex and kept for O/N at 4°C. Next day, beads complex 
was washed twice with 1 ml washing buffer and one more washing with 12 ml washing 
buffer in 15 ml falcon. Further, 100 µl of the provided DNA purifying slurry was used for 
purification coupled with boiling for de-crosslinking. Finally, 100 µl ChIP grade water 
was applied to elute target DNA and 2 µl of this DNA was used in a 10 µl final q-PCR 
reaction. 
2.2.8 Yeast-two hybrid screening and direct-yeast-two hybrid analysis 
To identify the interaction partners of Zfp819, we constructed a bait containing the 
N-terminal part (a.a. 1-343 corresponding to nucleotides (nt) 228-1256 of NM_028913.3) 
of Zfp819 (Zfp819_N) and screened the previously generated ESC cDNA library (Zheng 
et al., 2012) in a Yeast Two-Hybrid (Y2H) screening method. The GAL4-BD fusion bait 
construct of Zfp819 was prepared by cloning a PCR fragment of Zfp819_N into pGBKT7 
vector resulting in pGBKT7-Zfp819_N. After excluding the autoactivation by co-
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transformation of pGBKT7-Zfp819_N with empty pGADT7 vector into AH109 yeast 
strain, the bait construct was transformed into Y187 yeast strain. The Y2H screen was 
performed on ESC cDNA library using Matchmaker pre-transformed library protocol 
(Clontech). Briefly, the pre-transformed ESC library in yeast strain AH109 was mixed 
and mated together with strain Y187 containing the pGBKT7-Zfp819_N. After 24 h of 
mating, the culture was spread on SD/-Leu/-Trp/-His/-Ade plates and the surviving 
colonies were verified on SD/-Leu/-Trp/-His/-Ade/+ X-α-Gal plates. The positive clones 
that were blue on X-α-Gal were inoculated for O/N culture and the plasmid DNA was 
isolated using QIAprep Spin Miniprep Kit. By PCR amplification and sequencing using 
vector specific primers, we obtained the sequences of cDNA inserts. Identities of prey 
cDNA clones were determined by BLAST analysis. 
To test the auto-activation or interaction, the prey cDNA clones were co-
transformed with either empty pGBKT7 vector or pGBKT7-Zfp819_N into AH109 strain, 
respectively. The co-transformants were first selected on SD/-Leu/-Trp plates and later 
tested for the reporter gene expression on SD/-Leu/-Trp/-His/-Ade and X-α-Gal plates. 
The surviving clones without autoactivation were identified as putative interaction 
partners of Zfp819 and characterized further. 
2.2.9 Recombinant GST-Zfp819_N protein generation and GST-pull down assay 
2.2.9.1 Generation of pET-41a-Zfp819_N construct and protein purification 
The N-terminal region (a.a. 1-343 corresponding to nucleotides (nt) 228-1256 of 
NM_028913.3) of Zfp819 (Zfp819_N) was PCR amplified using Zfp819_GST_F 
Zfp819_GST_R primers and cloned in-frame to the downstream part of GST-tag in pET-
41a (+) vector to generate pET-41a-Zfp819_N.  
The recombinant construct as well as pET-41a alone were transformed separately 
into BL21competent cells to induce and purify GST-Zfp819_N and GST-only, 
respectively. Firstly, a single bacterial colony was inoculated into 20 ml of LB medium 
containing 50 µg/ml Kanamycin and incubated at 37°C with shaking. The next morning, 
5 ml O/N culture was diluted into 500 ml LB medium containing 50 µg/ml Kanamycin 
and cultured further at 37°C until the OD600 reached to ~0.6-0.8. Then 1 mM IPTG was 
added to induce the protein expression and incubated at 30°C for additional 5 h.  
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Cells were harvested by centrifugation at 5,000 x g for 15 min at 4°C. Subsequently, 
recombinant GST-Zfp819_N and GST-only were purified from bacterial cell extracts 
using GST•Bind Kit. Briefly, cells were harvested and resuspended in 20 ml of cold 1x 
GST Bind/Wash buffer and sonicated three times, 4 min each with an interval of 2 min to 
avoid the heat. The cell debris was removed by centrifugation at 20,000 x g for 20 min at 
4°C and the supernatant was filtered through a 0.45 µm membrane to prevent clogging of 
the resin. The resulting supernatant was applied onto a column made up of 2 ml washed 
glutathione-agarose resin and incubated for 1 h at 4°C. The bound resin was washed by 
washing with 10 ml 1x GST Bind/Wash buffer to remove the non-bound protein. 
Thereafter, the bound protein was eluted with 5 ml of 1x GST Elution buffer and 
collected as five 1 ml fractions. The elution sample (20 μl) from each fraction as well as 
input and flow through were resolved on 4-12% SDS-PAGE and stained with Coomassie 
blue staining solution. Purified protein was dialyzed O/N at 4°C against 1x GST 
Bind/Wash buffer prior to performing GST-pull down assay. 
2.2.9.2 GST-pull down assay 
Glutathione-agarose beads were mixed gently by inverting several times and 50 µl 
of beads for each reaction was transferred to a clean microcentrifuge tube followed by 
three times washing with 500 µl of 1x GST Bind/Wash buffer and centrifugation at 2,000 
rpm for 2 min. The supernatant was removed and beads were resuspended in 100 µl 1x 
GST Bind/Wash buffer. Then, 30 µg of either GST-Zfp819_N fusion protein or GST-
only were added to Glutathione-agarose beads and incubated at RT for 1 h followed by 
centrifugation at 2,000 rpm for 2 min and two times washing with 1x GST Bind/Wash 
buffer. At the meantime, total protein extracts were prepared from ESCs using RIPA 
buffer and 50µl of Glutathione-agarose beads were used for pre-cleaning of protein 
extracts by incubation at 4°C. After 3 h of incubation, the beads were centrifuged at 2,000 
rpm for 2 min and the resulting pre-cleaned protein extract was added to the centrifuge 
tube containing the bead-protein complex and the mixture was incubated O/N at 4°C on 
the roller. The next morning, beads were washed three times with 1 ml of 1x GST 
Bind/Wash buffer. Finally, the beads were resuspended in 2x GST Elution buffer, 
centrifuged and subjected to Western blot analysis for detecting either Chd4 or Kap1 
endogenous protein. 
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2.2.10 Southern blotting  
After electrophoresis of restriction enzyme digested gDNA, the gel was treated with 
0.25 M HCl for depurination for 7 min, with denaturation solution for 25 min and 
neutralisation for 20 min. The transfer of the DNA to the nylone membrane was done in a 
Turbo-Blot apparatus by capillary flow. Twenty six Whatman filter papers were layered 
on a Stack Tray, followed by 1 Whatman filter paper soaked in 2 x SSC. Then the 
equilibrated nitrocellulose membrane that was soaked in 2 x SSC was laid on the top. The 
treated agarose gel was placed on the membrane and covered by 2 x SSC soaked 
Whatman filter paper and 1 dry Whatman paper. Then the buffer tray was placed and 
filled with 2 x SSC. Finally a wick cover was put on top of the blot. The transfer was 
carried out for O/N. The next morning, DNA on the membrane was fixed by UV 
crosslinking in UV stratalinker 1800. 
Prehybridization was done in 12 ml of Rapid-hyb buffer with sheared denaturated 
salmon sperm DNA and incubated for 1 h in the hybridisation oven at 65°C. Then, the 
labelled probe was denaturated at 95°C for 10 min, chilled on ice for 5 min and added to 
the hybridisation solution. The hybridisation was carried out overnight in the oven. Next 
day, the membrane was washed for 10 min with 2 x SSC, then with 2 x SSC containing 
0.2% SDS at 65°C for 10-20 min. Finally, the membrane was washed with 0.2 x SSC 
containing 0.1 % SDS at the hybridisation temperature. After drying the membrane, it 
was sealed in a cassette and exposed to autoradiography overnight at -80°C. The film was 
developed in X-Ray Automatic Processor Curix 60. 
2.2.11 Computer analyses 
For the analysis of nucleotide sequences, programs like BLAST, BLAST2 and other 
programs from National Centre for Biotechnology Information (NCBI) were used 
(www.ncbi.nlm.nih.gov). For restriction analysis of DNA, NEB cutter V2.0 or Webcutter 
program were used (http://tools.neb.com/NEBcutter2/index.php; http://rna.lundberg.gu. 
se/cutter2). For primer design, Primer 3 software was used (http://Frodo.wi.mit.edu). 
ExPASy tools were used for proteins and their domains information (www.Expasy.org). 
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3 Results 
Ever since their first derivation in 1981, pluripotent stem cells have attracted 
biologists as well as physicians because of their potential in regenerative medicine 
applications. At the molecular level, pluripotency is established and maintained by both 
known as well as unknown regulatory mechanisms. Our previous efforts to identify 
unknown factors which might play a crucial role in establishment and maintenance of 
pluripotency uncovered Zfp819 as a putative pluripotency-related gene. In the present 
thesis, we endeavored to identify the function of Zfp819, a KRAB-zinc finger protein, in 
pluripotent stem cells as well as in mouse embryonic development. Most results of this 
thesis are included in the two following manuscripts, whereas unpublished results are 
included in the discussion part. 
The following result sections contain a brief description of the aim and results of the 
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3.1 Generation and characterization of yeast two-hybrid cDNA libraries derived 
from two distinct mouse pluripotent cell types 
Identification of protein-protein interaction networks will help us to dissect the 
pluripotency and differentiation potential of pluripotent cells, hence their efficient use in 
clinical applications. In the first part of this thesis, we developed two yeast two-hybrid 
(Y2H) cDNA libraries to identify potential interaction partners of a protein of interest. 
We used these libraries to identify interaction partners of Stra8 and Zfp819, which are 
highly expressed in pluripotent stem cells, yet the molecular function is unknown. These 
screens led us to identify several putative interaction proteins of both Stra8 and Zfp819, 
where some of these interactions were confirmed using both in vitro and in vivo 
approaches. Gene ontology (GO) categorization of putative Stra8 interaction proteins led 
us to suggest that Stra8 might function in chromatin organization and transcription 
regulation. Similarly, Zfp819 interaction proteins categorization revealed that Zfp819 
might play a role in transcription regulation, cell cycle, and apoptosis regulation as well 
as in telomere maintenance. Collectively, our Y2H libraries are a useful tool to identify 
potential protein interaction networks and their possible function in pluripotent stem cells. 
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3.2 Zfp819, a novel KRAB-zinc finger protein, interacts with KAP1 and functions in 
genomic integrity maintenance of mouse embryonic stem cells 
In the second part of this thesis, we set out to reveal the expression pattern and 
function of Zinc finger protein 819 (Zfp819), a novel pluripotency-related gene which we 
identified through the transcriptome comparison of undifferentiated and differentiated 
pluripotent stem cells. Firstly, Zfp819 was found to be expressed preferentially in 
undifferentiated pluripotent stem cells and in testis compared to differentiated cell types 
and adult mouse tissues. In order to reveal the function of Zfp819 in embryonic stem cells 
(ESCs), we performed both overexpression and downregulation studies in ESCs. 
However, we failed to detect any overt effect of Zfp819 downregulation and upregulation 
on pluripotency and differentiation networks of ESCs. Interestingly, we observed a 
significant overexpression of endogenous retroviral elements (ERVs) such as IAP and 
LINE 1 in Zfp819 downregulated cells. In support of these results, we identified the 
physical association of Zfp819 with the genomic regions of IAP elements as well as with 
KAP1, a universal co-repressor for KRAB-zinc finger proteins and known to repress 
ERVs. Moreover, we observed a spontaneous DNA damage and inefficiency of Zfp819 
downregulated cells to repair the induced DNA damage. Collectively, our findings reveal 
that Zfp819 functions in repression of ERVs thereby maintaining the genome stability of 
ESCs. 
Authors: Xiaoying Tan, Xingbo Xu, Ulrich Zechner, Jessica Nolte, Wolfgang Engel, 
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4 Discussion 
Pluripotency is established and maintained by many pluripotent stem cell-specific 
transcription factors and their coordinated autoregulatory and feedforward transcriptional 
regulatory mechanisms (Loh et al., 2006; Kashyap et al., 2009). Recent genome-wide 
studies on pluripotent stem cells have uncovered several new players in the 
transcriptional circuitry that maintain the pluripotency and differentiation potential of 
these cells. In the present study, we developed two high-quality yeast two-hybrid (Y2H)-
cDNA libraries, which can help in identification and construction of protein interactome 
of known and unknown pluripotent stem cell-specific protein(s). As a proof of concept, 
we have identified several interaction proteins of Zfp819, a novel pluripotent stem cell-
specific factor, using one of these Y2H-cDNA libraries. The identification of Zfp819 
interaction partners together with the molecular and functional studies revealed that 
Zfp819 functions in the regulation of genomic stability of pluripotent cells by suppressing 
a subset of endogenous retroviruses (ERVs). 
4.1 Methods for detection of protein-protein interactions  
Many biological processes are accomplished by the function and regulation of multi-
protein complexes in which one particular protein can be involved in various biological 
processes and might perform distinct functions. This extraordinary feat is achieved by 
formation of different protein complexes through interaction with various proteins. 
Identification of protein-protein interactions, the protein interactome, is therefore 
essential to understand the molecular function of any particular protein and its related 
biological processes. To this end, construction of protein interactomes has emerged as a 
new field to identify the proteins working in a concert to regulate various biological 
processes. Most human diseases account for the disruption of protein complexes and their 
functions due to mutations in either a single gene or in many genes (Lim et al., 2006; 
Lage et al., 2007; Vanunu et al., 2010). Therefore, protein interactomes have paved a way 
for medical researchers to seek for the protein interaction partners to dissect the 
pathological mechanism for many disease models (Oti et al., 2006; Lage et al., 2007). 
A variety of high throughput methods have been applied in global investigations of 
the interaction and relationship between two or more proteins. Currently, there are several 
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methods (Table 4.1) which are available to identify the protein-protein interaction 
networks. The high sensitivity and specificity are two primary pursuits for researchers. 
However, each of these approaches has its own advantages and drawbacks regarding the 
identification of protein interactions. Among the available techniques, Y2H system 
 
Table 4.1. Overview of various methods for identification of protein-protein interactions with a brief description 
of the method and the reference(s). (Table adapted and modified from Bruckner et al., 2009). 




The DNA binding domain and the activation domain of 
a transcription factor are separated and fused to two 
individual proteins. Only when two proteins interact 
with each other or come in close proximity leads to the 
transcriptional activation of reporter genes, thus the 
identification of protein interaction partner. 




The recombinant protein immobilized on the resin will 
aid in identification of protein interaction partners after 
passing the whole cell/tissue protein extract through the 
resin. After several steps to eliminate the unspecific 
bindings, interaction proteins are eluted and identified 
by mass spectrometry analysis. 
Jackson et al., 2002 
Tanaka et al., 2006 






IP-MS is based on protein immunoprecipitation (IP) 
method. The IPed fraction containing various proteins is 
subjected to peptide mass spectrometry analysis. 
Ewing et al., 2007 
Stable isotope 
labeling by amino 
acids in cells 
(SILAC) 
(in vivo) 
This method is an improved technique from IP-MS. It is 
based on the incorporation of amino acids with 
substituted stable isotopic nuclei. SILAC can not only 
detect the potential interaction partners but also quantify 
their ratios. 





A targeted reversible affinity probe called TRAP can 
find and couple with the bait protein. Then the TRAP 
can hunt the proteins which are nearby. Subsequently, 
the prey will be pulled down and identified by mass 
spectrometry. 
Yan et al., 2009 
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allows the most cost-effective and genomic-scale screening for protein-protein 
interactions with the potential to detect weak and transient interactions based on in vivo 
reporter systems (Fields and Song, 1989; Young, 1998). This approach relies on the 
activation of downstream reporter genes by the GAL4 based system (Fields and Song, 
1989; Young, 1998), in which the transcriptional activator GAL4 is split into DNA-
binding domain (BD) and activation domain (AD) and fused to bait and prey, 
respectively. The interaction between bait and prey proteins brings the GAL4 domains 
into close proximity leading to the transcriptional activation of downstream reporter 
genes (Fields and Song, 1989). 
The putative interaction partners identified by conventional Y2H methods are tend 
to produce false positive results at a low frequency, which are caused by the auto-
activation of the prey protein. Therefore, a modified Y2H, the repressed transactivator 
(RTA) system, was developed in order to inhibit the transcriptional activation of the prey 
proteins (Table 4.2). Moreover, the classic Y2H system cannot be applied to study the 
interaction of membrane associated proteins. Although the truncated proteins can be used 
and applied for classic Y2H system, it can lead to protein misfolding and can provide a 
high rate of false negatives (Sugita et al., 1996; Niethammer et al., 1996; Borg et al., 
1999). Therefore, the Son of Sevenless (SOS) and the Rat Sarcoma (RAS)-Recruitment 
Systems (SRS and RRS) were developed to use the RAS signaling activation as a readout, 
which is a cytosolic rather than the traditional transcriptional readout system (Table 4.2). 
In these two systems, the soluble bait protein is fused to mammalian SOS or RAS gene 
and its interaction with membrane localized prey proteins results in the activation of RAS 
signaling pathway and thereby in the survival of the cell. Taken together, the classical 
Y2H and its derivatives have shown powers by its methodological diversity and technical 
simplicity to rapidly screen and identify large amounts of reliable interaction partners of a 
protein. 
Due to lack of a pluripotent stem cell-specific Y2H cDNA library the Y2H approach 
was not feasible to study the pluripotency-related protein interactome. Therefore, in the 
present study, we constructed high quality cDNA libraries of mouse ESCs and maGSCs 
in a GAL4-based Y2H vector system. Subsequently, to characterize each library, we used 
Zfp819 and Stra8 (Stimulated by retinoic acid) as baits to screen interaction proteins 
using ESCs and maGSC libraries, respectively. Consequently, several putative interaction 
proteins of our baits could be identified (Zheng et al., 2012). 
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Table 4.2. Summary of classic Y2H method and its derivatives for detection of protein interaction partners 
which are in different sub-cellular localizations. (Table adapted and modified from Bruckner et al., 2009). 
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Among the 17 identified interaction proteins of Zfp819, we recognized that several of 
these proteins such as Chd4, Ctc1, and H3f3b are implicated in the genome integrity 
maintenance mechanisms. Chd4 is the core component of nucleosome-remodeling and 
histone deacetylases complex (NuRD), which is also composed of Hdac1/2, Chd3, Mta1 
and Mta2 (Lai and Wade, 2011). The loss of Chd4 function was found to result in early 
embryonic lethality and accumulation of DNA damage in cells (Larsen at al., 2010). Ctc1 
(CST telomere maintenance complex component 1) encodes a member of the mammalian 
homolog of yeast heterotrimeric CST telomeric capping complex. Mutations in human 
Ctc1 were shown to increase the spontaneous DNA damage (Surovtseva et al., 2009). 
H3f3b encodes a replacement histone variant which belongs to the histone 3 family 
(H3.3A and H3.3B) (Wu and Bonner, 1981; Brush et al., 1985; Wells et al., 1987) and 
was shown to function in genome stability and cell cycle control (De Luca et al., 2011). 
We could validate the interaction of Zfp819 with several of these interaction proteins 
using independent in vitro and in vivo methods such as co-immunoprecipitation (Co-IP), 
GST-pull down assay and co-localization studies. Collectively, the identification of 
Zfp819 interaction proteins directed us for the first time to study its possible role in 
transcriptional regulation and genomic integrity maintenance mechanisms. Similarly, we 
used maGSCs Y2H-cDNA library to screen for Stra8 interaction proteins (Zheng et al., 
2012). Several of these putative interaction proteins are implicated in chromatin 
assembly/modification and transcriptional regulation processes highlighting that Stra8 
might function in these processes. Furthermore, we selected AT-rich interactive domain 
4B (Arid4B) as a candidate and validated its interaction with Stra8 using Co-IP and co-
localization studies (Zheng et al., 2012). 
We generated two high quality Y2H-cDNA libraries from mouse ESCs and 
maGSCs and used them to identify protein interaction networks and to understand the 
molecular function of two pluripotency-related proteins, whose functions are unknown 
until now. Thus, we conclude that our pluripotent stem cell-specific Y2H cDNA libraries 
are powerful tools to study the protein interactomes of pluripotent stem cells. 
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4.2 KRAB zinc finger proteins function in pluripotent cells and in embryonic 
development 
Zinc finger proteins are one of the most abundant protein families in eukaryotic 
genomes (Urrutia, 2003). About one third of these zinc finger proteins bear a KRAB 
domain which is responsible for protein-protein interactions, whereas the C-terminus 
Cys2His2-zinc finger motif facilitates the recognition of a specific DNA sequence thereby 
leading to either gene activation or repression (Witzgall et al., 1994; Looman et al., 2002). 
Several lines of evidence suggest that KRAB-zinc finger proteins play an important role 
in maintenance of pluripotency, differentiation potential, cell proliferation, and cell cycle 
control as well as embryonic development. As outlined in Table 4.3, KRAB-zinc finger 
proteins can function in a Kap1 dependent manner as retrovirus repression factors (Wolf 
and Goff, 2009) or genomic methylation imprints maintenance factors in ESCs (Zuo et al., 
2011). Abnormal expression of KRAB-zinc finger proteins was reported to interfere with 
the lineage commitment of ESCs (Perrotti et al., 1995). Additionally, KRAB-zinc finger 
proteins are also found to be important for embryonic development and organ formation 
(Costoya et al., 2004; Garcia-Garcia et al., 2008; Krebs et al., 2012). Another group of  
 
Table 4.3. The list of Zinc finger proteins with a known function in pluripotent stem cells. The function of each 
zinc finger protein along with their reported expression pattern and the associated reference are indicated. * Stands for 
KRAB zinc finger protein. ERV- endogenous retrovirus elements; ICR- imprinting control region 
Gene Function Expression in organism References 
Zfp809* ERV repression Ubiquitously expressed Wolf and Goff, 2009 
ZFP57* ICR methylation regulation Brain, heart, kidney Li et al., 2008; Zuo et al., 2011 
Zfp568* Embryo development Brain, spinal cord, heart, liver Garcia-Garcia et al., 2008 
MZF1* ESC differentiation Ubiquitously expressed Perrotti et al., 1995 
Zfp819* ERV repression Testis, ovary, heart Present study 
Zfp206 Pluripotency maintainance 
Through embryogenesis and 
postnatal testis 
Yu et al., 2009 
Zfx ESCs self-renewal Kidney Galan-Caridad et al., 2007 
Zic3 Pluripotency maintainance Ubiquitously expressed Lim et al., 2007 
Zfp42 Pluripotency maintainance Placenta and testis Masui et al., 2008 
Sall4 Pluripotency regulation Kidney, liver, heart, brain Yang et al., 2008 
Zfp296 Inhibition of differentiation Kidney Fischedick et al., 2012 
Klf4 Pluripotency maintainance Ubiquitously expressed Bourillot and Savatier, 2010 
Zfp281 Pluripotency maintainance Ubiquitously expressed Wang et al., 2008 
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KRAB-zinc finger proteins is essential for tumor suppression and they are implicated in 
regulation of cell proliferation, induction of apoptosis through inhibition of oncogene(s) 
expression (Huang et al., 2007; Cheng et al., 2010). 
Although numerous studies have revealed the function of some of the KRAB-zinc 
finger proteins, the functions of a large number of KRAB-zinc finger proteins have to be 
further determined. In the present study (Tan et al., 2012, submitted), we identified 
Zfp819, a KRAB-zinc finger protein as a pluripotency-related gene. Interestingly, like 
many of the pluripotency-related genes, Zfp819 was confirmed as a transcriptional target 
of Oct3/4, Sox2, and Nanog in our study. The high expression of Zfp819 in various 
pluripotent cell types and the presence of transcriptionally active epigenetic marks at its 
promoter region suggest a possible crucial role of Zfp819 in pluripotent cells. 
4.3 Genome integrity maintenance in pluripotent stem cells 
All eukaryotic organisms have evolved with an organized process of cell division, 
which enables the genetic information to be accurately copied and distributed to the 
daughter cells. The maintenance of genome integrity is essential not only for the health of 
the individual organism but also for the continued survival and perpetuation of particular 
species (Tichy, 2011). However, the genome is under constant attack from endogenous 
and exogenous reactive chemical substances as well as viral infections thus likely leading 
to DNA damage (Geacintov and Broyde, 2010). 
Pluripotent stem cells are capable of giving rise to all the cell types in the entire 
organism. Any mutation or variation in stem cells could be fatal to the developing 
organism and even can affect the viability of the animal. In order to guard the genomic 
integrity, ESCs are highly sensitive to genotoxic reagents to repair damaged DNA or 
eliminate the defected cells, demonstrating notably lower spontaneous mutation 
frequency than somatic cells (Hong et al., 2006; Chuykin et al., 2008). 
The formation of DNA double strand breaks (DSBs) is the most severe form of 
DNA damage. Once the DSBs have happened, the DNA damage sensor protein ATM is 
immediately activated (Momcilovic et al., 2010) and phosphorylates the histone protein, 
H2AX, at ser-139. The phosphorylation of H2AX (γ-H2AX) is known as an indicator of 
the presence of DSBs (Rogakou et al., 1998) and was found to accumulate at the foci 
where several DSBs repair proteins are recruited (Paull et al., 2000). Recent studies have 
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identified a number of proteins which are involved in the maintenance of genome 
integrity. In 2010, Kap1 was found to play a role in genome protection through repression 
of ERVs (Rowe et al., 2010). Additionally, ATM-mediated phosphorylation of Kap1 leads 
to the latter’s co-localization with γ-H2AX, reflecting its correlation to DNA damage 
repair (White et al., 2006). Consistent with this, cells with loss of phosphorylated Kap1 
were shown to be hypersensitive to induced DNA damage and showed defects in 
chromatin decondensation, which is otherwise essential for repair process (Ziv et al., 
2006). Similarly, the chromodomain helicase protein, Chd4 was recently reported as a 
component of genome guardian machinery (Polo et al., 2010; Urquhart et al., 2011). The 
Chd4 depletion gives rise to accumulation of spontaneous DNA damage as well as 
elevated sensitivity for irradiation (Larsen at al., 2010). More recently, Pan et al. (2012) 
identified Chd4 as an important factor for controlling homologous recombination (HR) 
during the DNA damage repair process. 
In our studies (Zheng et al., 2012; Tan et al., 2012, submitted) we identified Kap1 
and Chd4 as interaction proteins of Zfp819 indicating that this novel KRAB-zinc finger 
protein may work in concert with Kap1 and Chd4 to maintain the genomic integrity in 
pluripotent stem cells. Furthermore, we also identified Ctc1, a component of telomere 
maintenance complex, and H3f3b, a histone variant, as potential interaction protein of 
Zfp819 (Zheng et al., 2012). Interestingly, these two interaction proteins were also 
implicated in regulating the genome stability and cell cycle control (Surovtseva et al., 
2009; De Luca et al., 2011), further strengthening the possible role of Zfp819 in genome 
integrity maintenance. In lines with these indications, we observed a very high level of 
spontaneous DNA damage in unstressed Zfp819-downregulated cells, indicating that 
Zfp819 depleted cells are inefficient in DNA damage repair or more prone to DNA 
damage.  
ERVs are another group of factors which pose threat to the genome stability of cells. 
As they can invade and duplicate within the host genome due to their transposition 
characteristic, ERVs are largely silenced. However, few elements of ERVs are expressed 
in placenta of human and other animals (Kalter et al., 1973; Levinson et al., 1978), 
lymphoid cells (Medstrand et al., 1992), mammary carcinoma cell lines (Patience et al., 
1996) as well as in mouse germ cells and preimplantation embryos (Brulet et al., 1985; 
Poznanski et al., 1991; Kigami et al., 2003; Evsikov et al., 2004). Very recently, 
Macfarlan et al. (2012) found a small portion of ESCs/iPSCs which expresses high levels 
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of 2-cell stage specific-ERV (MERVL-Gag). These 2C-like ESCs were shown to possess a 
potential to contribute not only to embryonic but also to extraembryonic tissues. This 
astonishing discovery suggested that the existence of ERVs is helpful for driving cell fate 
regulation in placental mammals. 
Since the retrotransposition can affect gene expression and lead to genome 
instability and other phenotypes (Doolittle et al., 1982; Maksakova et al., 2006), these 
ERVs are highly repressed in ESCs (Maksakova et al., 2011). A variety of pathways have 
been employed to repress the expression of them and to minimize the harmful impact on 
the host genome (Walsh and Bestor, 1999; Pannell et al., 2000; Matsui et al., 2010). DNA 
methylation is one such mechanism which is required for the stable repression of genes 
including ERVs, but is dispensable for ERVs suppression in pluripotent stem cells (Okano 
et al., 1999). In ESCs it is likely that there is also another alternative pathway involving 
histone modifications to suppress ERVs (Leung and Lorincz, 2011). Intriguingly, the 
evolution of KRAB-zinc finger proteins along with the appearance of ERVs, together 
with the functional data suggest that KRAB-zinc finger proteins recognize ERVs and 
repress their expression in a Kap1-dependent manner (Emerson and Thomas, 2009; Wolf 
and Goff, 2009).  
The protein structure of Kap1 contains an N-terminal RBCC domain, a TIF1 
signature sequence (TSS) and Heterochromatin protein 1 (HP1) binding domain in the 
centre with plant homeodomain (PHD) and bromodomain at the C-terminal (Iyengar and 
Farnham, 2011). The N-terminal RBCC domain is sufficient for interaction with KRAB-
zinc fingers. This interaction contributes to the silencing of the specific target genes 
which are recognized by KRAB-zinc fingers (Peng et al., 2000). Kap1 is thought to 
function as a co-repressor by assembling a complex with HP1 (Ryan et al., 1999). Further, 
PHD-bromodomain (PB) of Kap1 is physically associated with three chromatin 
modifying enzymes: ESET (Schultz et al., 2002), whose H3K9 histone methyltransferase 
activity suggests that KAP1 regulates transcription via changes in histone modifications at 
specific target sites. Further, the interaction of Kap1 with Chd3, a subunit of NuRD 
transcription repression complex (Schultz et al., 2001), as well as with the histone 
deacetylases (HDACs) (Nielsen et al., 1999) links the histone deacetylation to Kap1 
based gene repression. Fig 4.1 shows how Kap1 and KRAB zinc finger protein, Zfp809, 
regulate the repression of murine leukemia virus (MLV) in ESCs. Interestingly, we found 
very high expression levels of ERVs in Zfp819-downregulated cells indicating that 
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Zfp819 function in the suppression of ERVs (Tan et al., 2012, submitted). These 
observations are further strengthened by identifying a physical interaction between 
Zfp819 and Kap1/Chd4 (Tan et al., 2012, submitted; Zheng et al., 2012). 
 
 
Figure 4.1 Mechanism of ERVs silencing by KRAB-zinc finger protein and Kap1 in embryonic stem cells. The 
gene expression of murine leukemia virus (MLV), a type of ERVs, is regulated in cis by Kap1 and KRAB-zinc finger 
protein complex. The primer binding site (PBS) is essential to recruit Zfp809. Subsequent interaction between Zfp809 
and Kap1 leads to the interaction with HP1 to form ZFP809-KAP1-HP1complex. This leads to the establishment of 
repression chromatin marks H3K9me2 and virus silencing (Wolf and Goff, 2009; Figure adapted from Rowe and Trono, 
2011). 
4.4 Generation of gain-of-function and loss-of-function mouse models for Zfp819 
Genetically modified mice are commonly used animal models for demonstration of 
gene function in vivo. In the present study, we endeavored to develop both gain- and loss-
of-function mouse models of Zfp819 to better understand its role in embryonic 
development as well as in adult life. Firstly, we generated two Zfp819 overexpression 
models in which one model expresses Zfp819 constitutively whereas the other one is an 
inducible model (Fig.4.2). For the generation of constitutive model, the open reading 
frame (ORF) of Zfp819 along with additional C-terminal E2-epitope tag was cloned 
downstream of human elongation factor 1 alpha (hEF1α) promoter (Fig.4.2A). For the 
generation of the inducible model, we took advantage of the Tet-On system in which the 
expression of a cloned gene can be temporarily controlled by doxycycline 
supplementation. The Zfp819 ORF together with the FLAG-tag was cloned downstream 
of Tet responsive element (Tre) in a pTre vector system (Fig. 4.2B).   
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Figure 4.2 The scheme of two plasmid constructs used to generate Zfp819 overexpression models. (A) The 
constitutive expression vector in which the E2-tag fused Zfp819 will be expressed ubiquitously from highly active and 
constitutive promoter, hEF1α. (B) The schematic diagram showing the construct for producing Doxycycline inducible 
transgenic mouse line. An epitope Flag is tagged to the C- terminus of Zfp819 ORF, which is under the control of the 
Tet responsive element (Tre). The arrows indicate the location for the genotyping primers. 
The generated Zfp819 overexpression constructs were used for pronuclear injection. 
Subsequently, we obtained several founders for each transgenic line. The germline 
transmission of founders was confirmed by the genotyping PCR of their progeny (Fig. 
4.3). The generated pTre mice will be bred with already available Tet-On transgenic mice 
to establish a double transgenic mouse line, which will then be used to activate the 
expression of Zfp819 using doxycycline. Currently, the analysis of transgene integration 
site and copy numbers is in progress. Afterwards, the transgenic lines with high and low 
expression levels will be established to study the role of Zfp819 overexpression on mouse 
development. 
 
Figure 4.3 The genotyping-PCR results of Zfp819 constitutive (top) and inducible (bottom) transgenic mouse live 
progeny. This is an example of genotyping showing that 8 out of 10 from one liter are positive for hEF1α-Zfp819 
construct, whereas10 out of 11 from one liter are positive for pTre-Zfp819 construct. 
Generation of loss-of-function/knockout (KO) mouse models holds great promise to 
study the function of a gene (s) of interest and its associated phenotypes. Towards this 
end, we have obtained Zfp819 conditional KO ES cells from the International Knockout 
Mouse Consortium (IKMC). The blastocyst injections of these cells resulted in 
generation of high percentage chimeras. Although we tried to establish a homozygous 
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conditional KO mouse line using progeny of these chimeras, we were unable to obtain 
any offspring which are homozygous for the conditional allele. Subsequent analysis 
indicated that the conditional KO construct is integrated at the En2 gene locus (data not 
shown). Then we began to generate the classical KO construct using bacterial artificial 
chromosome (BAC)-mediated recombination approach (Liu et al., 2003). The strategy for 
generating the Zfp819 null allele is depicted in Fig. 4.4 A. Briefly, the BAC (CH29-
485C23), which contains the complete genomic locus of Zfp819, was used for the BAC-
mediated homologous recombination. The exons 2, 3 and 4 of Zfp819 which code for 
KRAB domain were replaced by a neomycin (neo) resistance cassette using homologous 
recombination. We confirmed the integration of neomycin cassette into the Zfp819 locus 
and the deletion of targeted exons 2, 3 and 4 in the BAC (Modified BAC) (Figure 4.4 B).  
 
Figure 4.4. The strategy for generating Zfp819 null allele. (A)The Neomycin cassette which is flanked by lox p sites 
was PCR amplified from vector pL452 using primers containing 50bp of each 5′ and 3′ micro arms (yellow and cyan 
rectangles) which are used for recombination. After homologous recombination, the targeting exons (exons 2, 3 and 4) 
are genetically replaced by neomycin resistance cassette (triangles). (B) The genotyping PCR result confirms the 
recombination of the Neo cassette and the deletion of exons 2, 3 and 4 in clones Nr.13 and Nr. 14. The locations of 
genotyping primers are indicated by arrows. 
In order to retrieve a part of the modified BAC (neo cassette flanked by ~4-5 kb of 
homologous arms) into the targeting vector pL253, we PCR amplified ~400 bp of each 5′ 
and 3′ mini arms and cloned them into NotI/HindIII and HindIII/BamHI restriction sites 
of pL253, respectively (Fig.4.5). Next, the HindIII linearized targeting vector will be used 
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targeting vector will be linearized with NotI and electroporated into ESCs. The successful 
homologous recombination into the Zfp819 locus will be confirmed by Southern blot 
analysis as illustrated (Fig.4.6). The ESCs with correct homologous recombination will 
then be used to generate chimera and subsequent Zfp819 KO mouse line. 
 
Figure 4.5. Generation of Zfp819 knockout construct. The 5’ and 3’ homology mini arms are amplified by PCR and 
sub-cloned into TK vector (PL253) using restriction enzymes (5’: NotI and HindIII, 3’: HindIII and BamHI). 

























Figure 4.6. The scheme for the verification of homologous recombination in Zfp819 locus. The targeting vector 
linearized by NotI will be electroporated in ESCs to generate the knockout allele. The Neo resistant ESC clones will be 
analyzed by Southern blot analysis for homologous recombination event of targeting construct into the Zfp819 locus. 
The Southern blot analysis of recombinant clones with 5’ external probe (green) should detect ~9.2 kb (KO) and ~7.5 
kb (WT) bands upon EcoRI digestion. Similarly, the Southern blot analysis with 3’ external probe (pink) should detect 









                                                                                                                              Discussion                         
 89
4.5 Future plans and perspectives 
The identification of Ctc1 and H3f3b as putative interaction proteins of Zfp819 is of 
particular interest, because both Ctc1 and H3f3b are known to function in the 
maintenance of telomeres. Further studies aimed at characterization of Zfp819 interaction 
with Ctc1 and H3f3b and subsequent studies on the role of Zfp819 in telomere 
maintenance will uncover its novel function in pluripotent stem cells.  
In the present study, we found that Zfp819 binds to IAP elements and suppresses 
their expression probably in a Kap1-dependent manner. Hence, it is interesting to identify 
the global Zfp819 binding sites/targets using ChIP-Sequencing (ChIP-Seq) experiments. 
These studies will reveal the global function of Zfp819 in pluripotent stem cells.   
To further investigate the developmental role of Zfp819, in the present study we 
started with the generation of gain- and loss-of-function mouse models. The 
characterization of these mouse models will thus lead to the identification of Zfp819 
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